Learning Objectives:

1. Describe the geriatric demography and epidemiology of ATTR cardiac amyloidosis.

2. Describe the mechanisms of disease that associate with aging.

3. Review available treatments and recently reported clinical trial results of emerging therapies. 


Presenter:
Frederick L. Ruberg, MD, Presenter, has no relevant financial relationships to disclose.
Faculty member does not plan on discussing unlabeled/investigational uses of a commercial product.

Session date: 
10/11/2024 - 9:00am to 10:00am EDT
Location: 
Boston University School of Medicine
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™

    Boston University Chobanian & Avedisian School of Medicine designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    • 1.00 MA End of Life Education
    • 1.00 MA Risk Management
  • 1.00 Participation
Please login or register to take this course.